LTRN
Price
$3.80
Change
+$0.06 (+1.60%)
Updated
Mar 14 closing price
Capitalization
40.98M
2 days until earnings call
MNMD
Price
$6.35
Change
+$0.04 (+0.63%)
Updated
Mar 14 closing price
Capitalization
478.59M
60 days until earnings call
Ad is loading...

LTRN vs MNMD

Header iconLTRN vs MNMD Comparison
Open Charts LTRN vs MNMDBanner chart's image
Lantern Pharma
Price$3.80
Change+$0.06 (+1.60%)
Volume$24.29K
Capitalization40.98M
Mind Medicine (MindMed)
Price$6.35
Change+$0.04 (+0.63%)
Volume$895.02K
Capitalization478.59M
LTRN vs MNMD Comparison Chart
Loading...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LTRN vs. MNMD commentary
Mar 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LTRN is a Hold and MNMD is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 16, 2025
Stock price -- (LTRN: $3.80 vs. MNMD: $6.35)
Brand notoriety: LTRN and MNMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LTRN: 25% vs. MNMD: 40%
Market capitalization -- LTRN: $40.98M vs. MNMD: $478.59M
LTRN [@Biotechnology] is valued at $40.98M. MNMD’s [@Biotechnology] market capitalization is $478.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $340.08B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LTRN’s FA Score shows that 1 FA rating(s) are green whileMNMD’s FA Score has 0 green FA rating(s).

  • LTRN’s FA Score: 1 green, 4 red.
  • MNMD’s FA Score: 0 green, 5 red.
According to our system of comparison, both LTRN and MNMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LTRN’s TA Score shows that 5 TA indicator(s) are bullish while MNMD’s TA Score has 4 bullish TA indicator(s).

  • LTRN’s TA Score: 5 bullish, 5 bearish.
  • MNMD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, LTRN is a better buy in the short-term than MNMD.

Price Growth

LTRN (@Biotechnology) experienced а +3.83% price change this week, while MNMD (@Biotechnology) price change was -7.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.40%. For the same industry, the average monthly price growth was -6.10%, and the average quarterly price growth was -7.72%.

Reported Earning Dates

LTRN is expected to report earnings on May 06, 2025.

MNMD is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (-1.40% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNMD($479M) has a higher market cap than LTRN($41M). LTRN YTD gains are higher at: 19.122 vs. MNMD (-8.764). LTRN has higher annual earnings (EBITDA): -21.18M vs. MNMD (-93.47M). MNMD has more cash in the bank: 295M vs. LTRN (28.1M). LTRN has less debt than MNMD: LTRN (291K) vs MNMD (24.3M). LTRN (0) and MNMD (0) have equivalent revenues.
LTRNMNMDLTRN / MNMD
Capitalization41M479M9%
EBITDA-21.18M-93.47M23%
Gain YTD19.122-8.764-218%
P/E RatioN/AN/A-
Revenue00-
Total Cash28.1M295M10%
Total Debt291K24.3M1%
FUNDAMENTALS RATINGS
MNMD: Fundamental Ratings
MNMD
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
86
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LTRNMNMD
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 19 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRDSX38.88N/A
N/A
T. Rowe Price Integrated US Sm Gr Eq
WRLDX35.72N/A
N/A
Scharf Global Opportunity Institutional
GLPSX39.68N/A
N/A
Goldman Sachs MLP Energy Infras R6
RIVBX31.86N/A
N/A
Riverbridge Growth Institutional
AGFGX11.05N/A
N/A
American Century Focused Global Gr R5

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with AXON. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
+1.60%
AXON - LTRN
36%
Loosely correlated
+4.06%
GLYC - LTRN
34%
Loosely correlated
+3.08%
INZY - LTRN
32%
Poorly correlated
+1.03%
MNMD - LTRN
32%
Poorly correlated
+0.63%
ORMP - LTRN
31%
Poorly correlated
N/A
More

MNMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNMD has been loosely correlated with ATAI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MNMD jumps, then ATAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNMD
1D Price
Change %
MNMD100%
+0.63%
ATAI - MNMD
47%
Loosely correlated
+6.47%
LABFF - MNMD
47%
Loosely correlated
N/A
IMRN - MNMD
44%
Loosely correlated
+0.21%
EYPT - MNMD
40%
Loosely correlated
-4.54%
VCYT - MNMD
40%
Loosely correlated
+3.52%
More